International Journal of Epidemiology, Volume 33, Number 1, pp. 68
IJE vol.33 no.1 © International Epidemiological Association 2004; all rights reserved.
Point-Counterpoint |
Commentary: Screening mammography: a decision analysis
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 447, Houston, TX 77030-4009, USA. E-mail: dberry@mdanderson.org
| The first 10% of the full text of this article appears below. |
Arguments over the credibility of the randomized screening mammography trials are red herrings. The overall results of the trials suggest that screening very likely reduces breast cancer mortality. Despite some peccadillos of the trials, I agree with the overall conclusion. I always have. So why have I been painted as being anti-screening? It is because I am less enthusiastic about the consequences of screening than are most medical researchers. And I believe that it is essential for women to understand and take into account
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. A Freedman, D. B Petitti, and J. M Robins Rejoinder Int. J. Epidemiol., February 1, 2004; 33(1): 69 - 73. [Full Text] [PDF] |
||||
